TNF-α is involved in the release of other mediators of the inflammation in CKD, such as IL-1, prostaglandins, oxygen radicals, NO, and platelet-activating factor [80,81] by activating the nuclear factor kappa B (NF-kB) and MAPK signaling pathways. Here, NFKB1 is linked to chronic kidney disease.